Evidence map›Paper›PMID 18418571›Full record

Trial reportIntensive care medicine2008

Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial.

Lorenzo Berra, Theodor Kolobow, Patrice Laquerriere, Betsey Pitts, Simone Bramati, Joshua Pohlmann, Chiara Marelli, Miriam Panzeri, Pietro Brambillasca, Federico Villa and 6 more

Open access · bronzeAbstract readClinical Trial, Phase IClinical Trial, Phase IIRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Antimicrobial Coating: Tracheal Tube Application.International journal of nanomedicine · 2022
    Review
  9. Review
  10. Avoiding ventilator-associated pneumonia: Curcumin-functionalized endotracheal tube and photodynamic action.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Observational
  12. Article
  13. Anti-biofilm Activity as a Health Issue.Frontiers in microbiology · 2016
    Review
  14. Observational
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Lorenzo BerraAnesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. lberra@partners.org
Theodor Kolobow
Patrice Laquerriere
Betsey Pitts
Simone Bramati
Joshua Pohlmann
Chiara Marelli
Miriam Panzeri
Pietro Brambillasca
Federico Villa
Andrea Baccarelli
Sylvie Bouthors
Henry T Stelfox
Luca M Bigatello
Joel Moss
Antonio Pesenti
University of Milano-Bicocca · ITMassachusetts General Hospital · USInserm · FRNational Heart Lung and Blood Institute · USHarvard University · USMontana State University · USNational Institutes of Health · US

Funding

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)ZIAHL002541 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MOSS, JOEL · 2009 to 2025
$47.7M
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)Z01HL002541 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MOSS, JOEL · 1996 to 2008
$4.5M
6 · The paper itself

Abstract

objectiveCoated medical devices have been shown to reduce catheter-related infections. We coated endotracheal tubes (ETT) with silver sulfadiazine (SSD), and tested them in a clinical study to assess the feasibility, safety, and efficacy of preventing bacterial colonization.

designA prospective, randomized clinical trial, phase I-II.

settingAcademic intensive care unit (ICU).

participantsForty-six adult patients expected to need 12-24 h of intubation were randomized into two groups.

interventionsPatients were randomized to be intubated with a standard non-coated ETT (St-ETT, n=23; control group), or with a SSD-coated ETT (SSD-ETT, n=23). MEASUREMENTS AND

resultsCoating with SSD prevented bacterial colonization of the ETT (frequency of colonization: SSD-ETT 0/23, St-ETT 8/23; p<0.01). No organized bacterial biofilm could be identified on the lumen of any ETT; however, SSD was associated with a thinner mucus layer (in the SSD-ETT secretion deposits ranged from 0 to 200 microm; in the St-ETT deposits ranged between 50 and 700 microm). No difference was observed between the two groups in the tracheobronchial brush samples (frequency of colonization: SSD-ETT 0/23, St-ETT 2/23; p=0.48). No adverse reactions were observed with the implementation of the novel device.

conclusionSSD-ETT can be safely used in preventing bacterial colonization and narrowing of the ETT in patients intubated for up to 24 h (mean intubation time 16 h).

Indexed as

AgedCoated Materials, BiocompatibleColony Count, MicrobialDisinfectantsEquipment ContaminationFemaleHumansIntubation, IntratrachealMaleMicroscopy, ConfocalMicroscopy, Electron, ScanningPneumonia, Ventilator-AssociatedPolyurethanesProspective StudiesSilver SulfadiazineStatistics, NonparametricCoated Materials, BiocompatibleDisinfectantsPolyurethanesSilver Sulfadiazine

Identifiers

PMID18418571
OpenAlexW2044240327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.